SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme

Clinical trial NCT00535379 · UNKNOWN

Trial details

NCT number: NCT00535379
Sponsor: Medical University Innsbruck
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2007-10-01
Primary completion: 2010-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.